Article Versions Notes

Palacka P, Pol’anová M, Svobodová A, Žigmond J, Zanchetta K, Gombárová V, Vulganová M, Slopovský J, Obertová J, Drgoňa Ľ, et al. Effectiveness, Adverse Events, and Immune Response Following Double Vaccination with BNT162b2 in Staff at the National Comprehensive Cancer Center (NCCC). Vaccines. 2022; 10(4):558. https://doi.org/10.3390/vaccines10040558

Palacka, Patrik, Monika Pol’anová, Alena Svobodová, Jan Žigmond, Katarína Zanchetta, Vlasta Gombárová, Martina Vulganová, Ján Slopovský, Jana Obertová, Ľuboš Drgoňa, and et al. 2022. "Effectiveness, Adverse Events, and Immune Response Following Double Vaccination with BNT162b2 in Staff at the National Comprehensive Cancer Center (NCCC)" Vaccines 10, no. 4: 558. https://doi.org/10.3390/vaccines10040558

Palacka, P., Pol’anová, M., Svobodová, A., Žigmond, J., Zanchetta, K., Gombárová, V., Vulganová, M., Slopovský, J., Obertová, J., Drgoňa, Ľ., Mego, M., & Pechan, J. (2022). Effectiveness, Adverse Events, and Immune Response Following Double Vaccination with BNT162b2 in Staff at the National Comprehensive Cancer Center (NCCC). Vaccines, 10(4), 558. https://doi.org/10.3390/vaccines10040558